Teleflex (NYSE:TFX) Price Target Raised to $125 by Royal Bank Of Canada

The medical technology company's stock received a price target increase from $115 to $125.

Mar. 3, 2026 at 5:55am

Got story updates? Submit your updates here. ›

Teleflex (NYSE:TFX), a diversified global provider of medical technologies, had its price target raised from $115 to $125 by Royal Bank Of Canada in a research note published on Friday. The firm currently has a 'sector perform' rating on the stock. Several other research firms have also recently issued reports on TFX, with ratings ranging from 'buy' to 'sell'.

Why it matters

Teleflex is a major player in the medical technology industry, providing critical care and surgical devices and solutions used by healthcare professionals. The change in price target by a prominent investment bank like Royal Bank Of Canada reflects analysts' views on the company's financial performance and growth prospects, which can impact investor sentiment and the stock price.

The details

In the research note, Royal Bank Of Canada cited Teleflex's recent quarterly earnings results, in which the company reported earnings per share of $1.93, missing analysts' consensus estimates of $3.73. The company also provided fiscal year 2026 guidance in the range of $6.25 to $6.55 per share. Other research firms have issued a range of ratings on Teleflex's stock, from 'buy' to 'sell', with price targets varying from $116 to $147.

  • The research note from Royal Bank Of Canada was published on Friday, February 28, 2026.
  • Teleflex reported its quarterly earnings results on Thursday, February 26, 2026.

The players

Teleflex Incorporated

A diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals.

Royal Bank Of Canada

A prominent investment bank that issued a research note and price target increase for Teleflex's stock.

Got photos? Submit your photos here. ›

What they’re saying

“We must not let individuals continue to damage private property in San Francisco.”

— Robert Jenkins, San Francisco resident

“Fifty years is such an accomplishment in San Francisco, especially with the way the city has changed over the years.”

— Gordon Edgar, grocery employee

The takeaway

The change in price target for Teleflex's stock reflects the ongoing analysis and scrutiny of the medical technology company's performance and growth prospects by the investment community. As a major player in the industry, Teleflex's financial results and outlook can have broader implications for the sector and investor sentiment.